Logo

Pathwork Diagnostics Gets CAP Accreditation

Mar 29, 2011

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Pathwork Diagnostics today said that it has received accreditation from the College of American Pathologists.

Patthwork Diagnostics offers its Tissue of Origin test through its CLIA lab. The test measures the gene expression levels of more than 2,000 genes to help identify the origin of metastatic and poorly differentiated tumors.

Last year, the firm received US Food and Drug Administration clearance for the test.

Filed under

Molecular Diagnostics
Regulatory News & FDA Approvals
Microarrays & Multiplexing
Diagnostics
Cancer
CAP
microarrays
Pathwork Diagnostics
Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.